DONG Jian-jian, HAN Yong-zhu, CHENG Nan. Molecular Regulatory Mechanism of Gandou Decoction on Copper Metabolism Pathway in Hepatocytes of Wilson's Disease Model-TX Mice[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(24): 128-133.
DONG Jian-jian, HAN Yong-zhu, CHENG Nan. Molecular Regulatory Mechanism of Gandou Decoction on Copper Metabolism Pathway in Hepatocytes of Wilson's Disease Model-TX Mice[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(24): 128-133. DOI: 10.13422/j.cnki.syfjx.2016240128.
Objective: To detect the molecular target of copper transport pathway in hepatocytes of TX mice with Gandou decoction (GDD) treatment
and explore its corresponding regulatory metabolism. Method: Totally 20 rabbits were randomly divided into normal group (normal saline) and GDD group (4.5 g·kg-1·d-1) after adaptive feeding for 3 days. Treatment was given by ig
bid
for 10 days to obtain drug serum. Hepatocytes of DL and TX mice were isolated and extracted by 2 step perfusion method; atomic absorption method was used to detect the concentration of microelement in the hepatocytes of TX mice after treatment with rabbit serum containing different concentrations of GDD; and another blank group was set up. Western blot was used to detect the expression levels of adenosine triphosphate7b (ATP7b)
anti-oxidant1 (ATOX1)
copper transporter1 (CTR1)
metallothionein (MT)
copper chaperone of superoxide dismutase (CCS)
and cytochrome-coxidase17 (COX17) in the hepatocytes of TX mice after being treated with rabbit serum containing GDD. Result: As compared with blank group
the contents of copper and iron were increased; the content of zinc was reduced; the protein expression levels of ATP7b
ATOX1 CCS
COX17 were significantly reduced
and the protein expression levels of MT
CTR1 were significantly increased in hepatocytes of model group TX mice (P<0.01). As compared with the model group
GDD could reduce the contents of copper and iron in the hepatocytes of TX mice
and increase the content of zinc in a dose-dependent manner(P<0.05
P<0.01). Western blot results indicated that GDD could significantly increases the protein expression levels of ATP7b
ATOX1 CCS
COX17 (P<0.05
P<0.01)and decrease the protein expression levels of MT
CTR1 in the hepatocytes of TX mice (P<0.01). Conclusion: GDD may increases the copper excretion in hepatocytes of TX mice by up-regulating the protein expression levels of ATP7b
ATOX1
CCS
COX17 and down-regulating the expression levels of CTR1 and MT. GDD could reduce copper contents in hepatocytes through a multi-target and multi-channel regulation of copper metabolism pathway.